Sort
82,697 grants matching “vaccine development”
Understanding and Altering the Virologic Setpoint
$1,427,737Aaron Diamond Aids Research Center · U01 · FY2002 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,427,717Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2024 · AI
Vaccines for Extensively Drug Resistant Tuberculosis
$1,427,671William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2012 · AI
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
$1,427,603David B. Weiner · Wistar Institute · U19 · FY2023 · AI
Innate inflammatory responses during pulmonary infections
$1,427,583Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,427,583Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2011 · AI
High-throughput identification of antibody features for sequence-based epitope prediction
$1,427,400Nicholas C. Wu · University Of Illinois At Urbana-Champaign · DP2 · FY2021 · AT
Host Immunity Against Bacteria
$1,427,388Ian Myles · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Preclinical development of semisynthetic saponin immunological adjuvant Titerquil-1055 in the context of an influenza vaccine
$1,427,022Tyler Martin · Adjuvance Technologies, Inc. · N43 · FY2019 · AI
Computational Biology and Biostatistics Core
$1,426,768Bette T. Korb · Duke University · U19 · FY2009 · AI
COMBINATORIAL APPROACHES TO TREAT NEOPLASTIC DISEASES
$1,426,535Torrey Pines Inst For Molecular Studies · P01 · FY2000 · CA
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,426,271Eric Hunter · Emory University · R01 · FY2014 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,426,271Eric Hunter · Emory University · R01 · FY2012 · AI
Immunity to Pulmonary Infections
$1,426,152Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,425,978John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach
$1,425,941Tim Alan Ahles · Sloan-Kettering Inst Can Research · U54 · FY2023 · CA
Influenza Vaccine Development
$1,425,675Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach
$1,425,606Tim Alan Ahles · Sloan-Kettering Inst Can Research · U54 · FY2022 · CA
Food & Waterborne Diseases Integrated Research Network
$1,425,518Susan Mansfield · Michigan State University · N01 · FY2009 · AI
Tick saliva and its importance for tick feeding and pathogen transmission
$1,425,396Lucas Tirloni · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Dynamics of Protein Assemblies by Analytical Ultracentrifugation
$1,425,266Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2024 · EB
EMORY/ATLANTA CENTER FOR AIDS RESEARCH(CFAR)
$1,425,219Emory University · P30 · FY2003 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$1,425,149Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted
$1,424,623Johns Hopkins University · U19 · FY2005 · AI
Small-molecule inhibitors of flavivirus entry
$1,424,274Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2018 · AI